Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1999 Oct;45:2381–2393.

Clinical effectiveness of pneumococcal vaccine. Meta-analysis.

B G Hutchison 1, A D Oxman 1, H S Shannon 1, S Lloyd 1, C A Altmayer 1, K Thomas 1
PMCID: PMC2328641  PMID: 10540698

Abstract

OBJECTIVE: To determine the clinical effectiveness of pneumococcal vaccine. DATA SOURCES: Computerized searches of MEDLINE, EMBASE, and SCISEARCH databases were performed, reference lists of retrieved articles were reviewed, and first authors of published studies were contacted. STUDY SELECTION: Studies of use of pneumococcal vaccines in adults were included if the study design was a randomized or quasi-randomized controlled trial and at least one of the following clinical outcomes was reported: vaccine-type systemic pneumococcal infection, systemic pneumococcal infection, vaccine-type pneumococcal pneumonia, pneumococcal pneumonia, non-vaccine-type pneumococcal pneumonia. SYNTHESIS: Study quality was assessed and descriptive information concerning the study populations, interventions, and outcome measurements was extracted for 13 trials involving more than 65,000 patients. Estimates of vaccine efficacy, based on a meta-analysis of randomized and quasi-randomized trials, were determined for clinical outcomes. CONCLUSIONS: Vaccination with pneumococcal polysaccharide vaccine can be expected to reduce the risk of systemic infection due to pneumococcal types included in the vaccine by 83% and systemic infection due to all pneumococci by 73%. We found no evidence that the vaccine was less efficacious for the elderly, institutionalized people, or those with chronic disease.

Full text

PDF
2381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austrian R., Douglas R. M., Schiffman G., Coetzee A. M., Koornhof H. J., Hayden-Smith S., Reid R. D. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians. 1976;89:184–194. [PubMed] [Google Scholar]
  2. Austrian R. Maxwell Finland Lecture. Random gleanings from a life with the pneumococcus. J Infect Dis. 1975 Apr;131(4):474–484. doi: 10.1093/infdis/131.4.474. [DOI] [PubMed] [Google Scholar]
  3. Austrian R. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines. J Infect Dis. 1977 Aug;136 (Suppl):S38–S42. doi: 10.1093/infdis/136.supplement.s38. [DOI] [PubMed] [Google Scholar]
  4. Barrett-Connor E. The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis. 1971 Jun;103(6):845–848. doi: 10.1164/arrd.1971.103.6.845. [DOI] [PubMed] [Google Scholar]
  5. Bentley D. W., Ha K., Mamot K., Moon D., Moore L., Poletto P., Springett A. Pneumococcal vaccine in the institutionalized elderly: design of a nonrandomized trial and preliminary results. Rev Infect Dis. 1981 Mar-Apr;3 (Suppl):S71–S81. doi: 10.1093/clinids/3.supplement_1.s71. [DOI] [PubMed] [Google Scholar]
  6. Bentley D. W. Vaccinations. Clin Geriatr Med. 1992 Nov;8(4):745–760. [PubMed] [Google Scholar]
  7. Breiman R. F., Spika J. S., Navarro V. J., Darden P. M., Darby C. P. Pneumococcal bacteremia in Charleston County, South Carolina. A decade later. Arch Intern Med. 1990 Jul;150(7):1401–1405. [PubMed] [Google Scholar]
  8. Butler J. C., Breiman R. F., Campbell J. F., Lipman H. B., Broome C. V., Facklam R. R. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA. 1993 Oct 20;270(15):1826–1831. [PubMed] [Google Scholar]
  9. Davis A. L., Aranda C. P., Schiffman G., Christianson L. C. Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study. Chest. 1987 Aug;92(2):204–212. doi: 10.1378/chest.92.2.204. [DOI] [PubMed] [Google Scholar]
  10. Duclos P., Arruda H., Dessau J. C., Dion R., Dupont M., Gaulin C., Grenier J. L., Savard M., Trudeau G., Douville-Fradet M. Immunization survey of non-institutionalized adults--Quebec (as of May 30, 1996). Can Commun Dis Rep. 1996 Nov 1;22(21):177–181. [PubMed] [Google Scholar]
  11. Fedson D. S. Influenza and pneumococcal immunization strategies for physicians. Chest. 1987 Mar;91(3):436–443. doi: 10.1378/chest.91.3.436. [DOI] [PubMed] [Google Scholar]
  12. Fedson D. S. Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: what can the two countries learn from each other? Clin Infect Dis. 1995 May;20(5):1371–1376. doi: 10.1093/clinids/20.5.1371. [DOI] [PubMed] [Google Scholar]
  13. Fedson D. S. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness. Semin Respir Infect. 1993 Dec;8(4):285–293. [PubMed] [Google Scholar]
  14. Fiebach N., Beckett W. Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines. Arch Intern Med. 1994 Nov 28;154(22):2545–2557. [PubMed] [Google Scholar]
  15. Fine M. J., Smith M. A., Carson C. A., Meffe F., Sankey S. S., Weissfeld L. A., Detsky A. S., Kapoor W. N. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med. 1994 Dec 12;154(23):2666–2677. doi: 10.1001/archinte.1994.00420230051007. [DOI] [PubMed] [Google Scholar]
  16. Forrester H. L., Jahnigen D. W., LaForce F. M. Inefficacy of pneumococcal vaccine in a high-risk population. Am J Med. 1987 Sep;83(3):425–430. doi: 10.1016/0002-9343(87)90751-0. [DOI] [PubMed] [Google Scholar]
  17. Gaillat J., Zmirou D., Mallaret M. R., Rouhan D., Bru J. P., Stahl J. P., Delormas P., Micoud M. Essai clinique du vaccin antipneumococcique chez des personnes âgées vivant en institution. Rev Epidemiol Sante Publique. 1985;33(6):437–444. [PubMed] [Google Scholar]
  18. Gardner P., Schaffner W. Immunization of adults. N Engl J Med. 1993 Apr 29;328(17):1252–1258. doi: 10.1056/NEJM199304293281708. [DOI] [PubMed] [Google Scholar]
  19. Hahn H. H., Beaty H. N. Transtracheal aspiration in the evaluation of patients with pneumonia. Ann Intern Med. 1970 Feb;72(2):183–187. doi: 10.7326/0003-4819-72-2-183. [DOI] [PubMed] [Google Scholar]
  20. Hirschmann J. V., Lipsky B. A. The pneumococcal vaccine after 15 years of use. Arch Intern Med. 1994 Feb 28;154(4):373–377. [PubMed] [Google Scholar]
  21. Istre G. R., Tarpay M., Anderson M., Pryor A., Welch D. Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance. J Infect Dis. 1987 Nov;156(5):732–735. doi: 10.1093/infdis/156.5.732. [DOI] [PubMed] [Google Scholar]
  22. Jain A., Jain S., Gant V. Should patients positive for HIV infection receive pneumococcal vaccine? BMJ. 1995 Apr 22;310(6986):1060–1062. doi: 10.1136/bmj.310.6986.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Keller D. W., Breiman R. F. Preventing bacterial respiratory tract infections among persons infected with human immunodeficiency virus. Clin Infect Dis. 1995 Aug;21 (Suppl 1):S77–S83. doi: 10.1093/clinids/21.supplement_1.s77. [DOI] [PubMed] [Google Scholar]
  24. Klastersky J., Mommen P., Cantraine F., Safary A. Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma. Eur J Cancer Clin Oncol. 1986 Jul;22(7):807–813. doi: 10.1016/0277-5379(86)90367-6. [DOI] [PubMed] [Google Scholar]
  25. LaForce F. M. Immunizations, immunoprophylaxis, and chemoprophylaxis to prevent selected infections. US Preventive Services Task Force. JAMA. 1987 May 8;257(18):2464–2470. [PubMed] [Google Scholar]
  26. Leech J. A., Gervais A., Ruben F. L. Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease. CMAJ. 1987 Feb 15;136(4):361–365. [PMC free article] [PubMed] [Google Scholar]
  27. Macleod C. M., Hodges R. G., Heidelberger M., Bernhard W. G. PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES. J Exp Med. 1945 Nov 30;82(6):445–465. [PMC free article] [PubMed] [Google Scholar]
  28. Obaro S. K., Monteil M. A., Henderson D. C. The pneumococcal problem. BMJ. 1996 Jun 15;312(7045):1521–1525. doi: 10.1136/bmj.312.7045.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Oxman A. D., Cook D. J., Guyatt G. H. Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA. 1994 Nov 2;272(17):1367–1371. doi: 10.1001/jama.272.17.1367. [DOI] [PubMed] [Google Scholar]
  30. Riley I. D., Tarr P. I., Andrews M., Pfeiffer M., Howard R., Challands P., Jennison G. Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community. Lancet. 1977 Jun 25;1(8026):1338–1341. doi: 10.1016/s0140-6736(77)92552-1. [DOI] [PubMed] [Google Scholar]
  31. Shapiro E. D., Berg A. T., Austrian R., Schroeder D., Parcells V., Margolis A., Adair R. K., Clemens J. D. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991 Nov 21;325(21):1453–1460. doi: 10.1056/NEJM199111213252101. [DOI] [PubMed] [Google Scholar]
  32. Shapiro E. D., Clemens J. D. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann Intern Med. 1984 Sep;101(3):325–330. doi: 10.7326/0003-4819-101-3-325. [DOI] [PubMed] [Google Scholar]
  33. Simberkoff M. S., Cross A. P., Al-Ibrahim M., Baltch A. L., Geiseler P. J., Nadler J., Richmond A. S., Smith R. P., Schiffman G., Shepard D. S. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Nov 20;315(21):1318–1327. doi: 10.1056/NEJM198611203152104. [DOI] [PubMed] [Google Scholar]
  34. Simberkoff M. S. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness. Semin Respir Infect. 1993 Dec;8(4):294–299. [PubMed] [Google Scholar]
  35. Sims R. V., Steinmann W. C., McConville J. H., King L. R., Zwick W. C., Schwartz J. S. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med. 1988 May;108(5):653–657. doi: 10.7326/0003-4819-108-5-653. [DOI] [PubMed] [Google Scholar]
  36. Smit P., Oberholzer D., Hayden-Smith S., Koornhof H. J., Hilleman M. R. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA. 1977 Dec 12;238(24):2613–2616. [PubMed] [Google Scholar]
  37. Torzillo P. J. Pneumococcal vaccine: current status. Aust N Z J Med. 1993 Jun;23(3):285–290. doi: 10.1111/j.1445-5994.1993.tb01734.x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES